| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |